AVHHL — AVITA Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1762303 ·
Last close
$2.00
Market Cap
$309.27M
52W High
$2.00
52W Low
$0.56
ADV30
790
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 21,702,000 | 17,767,000 | -6,855,000 | -7,663,000 | 47,777,000 | 9,139,000 | 75,615,000 |
| Mar 2026 | 19,251,000 | 15,728,000 | -8,803,000 | -10,611,000 | 51,544,000 | 8,309,000 | 74,710,000 |
| Dec 2025 | 17,615,000 | 14,311,000 | -10,408,000 | -11,621,000 | 56,392,000 | 10,243,000 | 73,042,000 |
| Sep 2025 | 17,062,000 | 13,875,000 | -9,153,000 | -13,187,000 | 63,728,000 | 15,422,000 | 70,394,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-24,225,000
Investing CF
$600,000
Financing CF
$20,548,000
CapEx
$-1,114,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.29
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-426,675,000
Inventory
$5,287,000
Receivables
$9,867,000
ST Investments
$1,996,000
EBIT TTM
$-37,657,000
Pretax Income TTM
$-43,062,000
Interest Exp TTM
$5,405,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$75,631,000
EBITDA
$-32,764,000
Free Cash Flow
$-13,347,875
Enterprise Value
$99,199,696
Total Cash
$11,135,000
Total Debt
$48,481,000
Shares Out
154,634,235
Trailing EPS
$-0.29
Book Value
$-0.90
ROE
—
ROA
-41.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 71,610,000 | -42,534,000 | -48,587,000 | 56,392,000 | 73,042,000 | -16,650,000 | -31,195,000 |
| Dec 2024 | 64,251,000 | -56,593,000 | -61,845,000 | 79,711,000 | 75,212,000 | 4,499,000 | -48,939,000 |
| Dec 2023 | 50,143,000 | -42,655,000 | -35,381,000 | 111,640,000 | 62,584,000 | 49,056,000 | -38,011,000 |
| Dec 2022 | 34,421,000 | -27,505,000 | -26,665,000 | 98,264,000 | 13,524,000 | 84,740,000 | -19,090,000 |
TTM Snapshot
Revenues TTM
$30,390,000
NetIncome TTM
$-30,786,000
OpCashFlow TTM
$0
Assets (Latest)
$79,711,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MOBI | Mobia Medical, Inc. | $301.62M | $9.06 | — |
| SMTI | Sanara MedTech Inc. | $322.13M | $35.06 | — |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $292.66M | $4.50 | — |
| CV | CapsoVision, Inc | $332.81M | $6.65 | — |
| EMBC | Embecta Corp. | $334.29M | $5.90 | — |
News headlines (Yahoo Finance, 1h cache)
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
2026-09-02 20:10 · Yahoo
All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy
2026-08-31 16:00 · Yahoo
AVITA Medical (RCEL) Stock Fair Value Rises After PermeaDerm Data And Analyst Target Increases
2026-08-25 17:07 · Yahoo
Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?
2026-08-24 16:00 · Yahoo
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft
2026-08-19 12:02 · Yahoo
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
2026-08-18 11:45 · Yahoo
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%
2026-08-16 22:01 · Yahoo
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds
2026-08-16 21:01 · Yahoo
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript
2026-08-13 22:15 · Yahoo
AVITA Medical to Host Investor Webinar Briefing
2026-08-09 22:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.